Eldec Pharmaceuticals, Inc.
Pharmaceutical company · Chapel Hill, North Carolina, United States
Eldec Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Chapel Hill, North Carolina, United States. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $5.4 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $200,000 sold in a notice filed in 2026.
Eldec Pharmaceuticals at a glance
What does Eldec Pharmaceuticals do?
US government research funding
7 SBIR/STTR small-business research awards from US health agencies, $5.4 million in total (2018 to 2025). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $200,000 sold (2026).
Frequently asked questions about Eldec Pharmaceuticals
Where is Eldec Pharmaceuticals headquartered?
Eldec Pharmaceuticals, Inc. is headquartered in Chapel Hill, North Carolina, United States.
What does Eldec Pharmaceuticals do?
Eldec Pharmaceuticals, Inc. is a pharmaceutical company.
Similar companies
- Tenax Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Renovion, Inc.Chapel Hill, North Carolina, United States
- Amalgent Therapeutics, LLCChapel Hill, North Carolina, United States
- Cardioxyl Pharmaceuticals IncChapel Hill, North Carolina, United States
- Belhaven Biopharma Inc.Chapel Hill, North Carolina, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences